NCT06794645 2025-01-27
Pembrolizumab and Pemetrexed for Progressive Chordoma
Saint John's Cancer Institute
Phase 2 Recruiting
Clinical Trials
7 trialsNCT03809637 2024-12-18
A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue Sarcoma
Yonsei University
Phase 2 Completed
NCT03955042 2023-03-07
Pemetrexed for the Treatment of Chordoma
Saint John's Cancer Institute
Phase 1 Completed
NCT00860015 2020-08-25
Alimta Plus Gemcitabine for Advanced Sarcoma
Columbia University
Phase 2 Completed
NCT00276783 2020-03-05
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
Phase 2 Unknown
NCT00703638 2017-11-29
Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00427466 2009-02-16
Pemetrexed in Patients With Soft Tissue Sarcoma
University Hospital Tuebingen
Phase 2 Completed